ストックスクリーナーアプリを入手
6.11
6.26%
0.36
Avita Medical Inc (RCEL) 最新ニュース
AVITA Medical, Inc. (NASDAQ:RCEL) Short Interest Up 23.9% in May - MarketBeat
RCEL: AVITA Medical Maintains Buy Rating with $19 Price Target | - GuruFocus
D. Boral Capital Reaffirms "Buy" Rating for AVITA Medical (NASDAQ:RCEL) - MarketBeat
Avita Medical (RCEL) Unveils Promising Results for Cohealyx in Wound Treatment | RCEL Stock News - GuruFocus
AVITA Medical’s Cohealyx shows promise in wound care - Investing.com
AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™ | RCEL Stock News - GuruFocus
AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™ - The Manila Times
AVITA Medical’s Cohealyx shows promise in wound care By Investing.com - Investing.com UK
Avita Medical Stockholders Approve Key Amendments and Elections - TipRanks
Transcript : AVITA Medical, Inc.Shareholder/Analyst Call - marketscreener.com
(RCEL) Investment Report - news.stocktradersdaily.com
AVITA Medical’s RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards - Yahoo Finance
AVITA Medical's RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards | RCEL Stock News - GuruFocus
No normal is the new normal - The Globe and Mail
Revolutionary Wound Care Tech RECELL Crowned Best Surgical Innovation: How 30,000 Patients Benefited - Stock Titan
Stocks in play: Fury Gold Mines Limited - The Globe and Mail
Translational Regenerative Medicine Market Is Booming So Rapidly | Athersys, Avita Medical, AxoGen - openPR.com
Deutsche Bank AG Has $292,000 Holdings in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Avita Medical stock hits 52-week low at $5.54 amid market challenges - Investing.com Canada
Is Abercrombie & Fitch Stock a Buy in June 2025? - The Globe and Mail
Shareholders Will Probably Not Have Any Issues With AVITA Medical, Inc.'s (NASDAQ:RCEL) CEO Compensation - simplywall.st
Is Amazon Stock Ready for a Significant Rebound? - The Globe and Mail
Jane Street Group LLC Sells 36,440 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Delta Investment Management LLC Buys 38,042 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) - MarketBeat
(RCEL) Trading Signals - news.stocktradersdaily.com
Northern Trust Corp Raises Stock Holdings in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Will AVITA's Burn Care Breakthroughs Deliver A Healing Touch For Investors? - RTTNews
FY2025 EPS Estimates for AVITA Medical Boosted by Analyst - MarketBeat
Why Avita Medical, GenusPlus, Mesoblast, and Polynovo shares are storming higher - MSN
Price T Rowe Associates Inc. MD Sells 9,796 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Avita Medical Updates Bylaws for Governance Enhancement - TipRanks
Cantor Fitzgerald Comments on AVITA Medical FY2025 Earnings - Defense World
(RCEL) Technical Data - news.stocktradersdaily.com
AVITA downgraded by Piper Sandler over sales outlook - MSN
AVITA Medical's Acute Wound Care Showcase 2025 Streams Live Today - The Manila Times
AVITA Medical’s Acute Wound Care Showcase 2025 Streams Live Today - Yahoo Finance
AVITA Medical: Near Perfect Execution Needed To Navigate Through Balance Sheet Challenges - Seeking Alpha
Why AVITA, Botanix, Brainchip, and NAB shares are falling today - The Motley Fool Australia
Analysts Have Been Trimming Their AVITA Medical, Inc. (NASDAQ:RCEL) Price Target After Its Latest Report - Yahoo Finance
Contrasting GBS (NYSE:GBS) and AVITA Medical (NASDAQ:RCEL) - Defense World
Wells Fargo & Company MN Boosts Stock Position in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
AVITA Medical, Inc. (NASDAQ:RCEL) Q1 2025 Earnings Call Transcript - Insider Monkey
Cantor maintains Avita Medical stock Overweight, $19 target post-Q1 By Investing.com - Investing.com Canada
AVITA Medical outlines $3.5B US market opportunity with expanded product portfolio and 2025 revenue guidance - MSN
Avita Medical (RCEL) Target Price Adjusted by TD Cowen | RCEL St - GuruFocus
Avita Medical Shares Decline on 1Q Revenue Miss - MarketWatch
Barclays PLC Purchases 3,526 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Avita’s Road to Profitability Is in Sight - Morningstar
AVITA Medical (RCEL) Sees Revenue Surge with Product Launches - GuruFocus
AVITA Medical Inc (AVHHL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
AVITA Medical Inc (AVHHL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada
Avita shares plunge despite Q1 revenue lift - Capital Brief
AVITA Medical Inc (AVHHL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic Shifts - GuruFocus
AVITA Medical Reports Strong Q1 2025 Growth - TipRanks
Avita Medical's Loss Narrows in Q1 as Revenue Grows; Shares Down 20% - marketscreener.com
AVITA Medical Inc reports results for the quarter ended March 31Earnings Summary - TradingView
AVITA Medical (RCEL) Reports Significant Revenue Growth with New Product Launches | RCEL Stock News - GuruFocus
0.56%
1.70%
大文字化:
|
ボリューム (24 時間):